abstract |
The present application relates to a fixed dose combination comprising lacosamide and levetiracetam, as well as to dosage regimes including such fixed dose combinations. The fixed dose combinations are suitable for the oral or parenteral treatment of various diseases, including epilepsy and/or epileptic seizures. |